Overview

Thiamine Supplementation in Patients With Septic Shock

Status:
Withdrawn
Trial end date:
2019-03-14
Target enrollment:
Participant gender:
Summary
To determine if intravenous thiamine would decrease the time to reversal of shock in patients with septic shock.
Phase:
Phase 1
Details
Lead Sponsor:
The Cleveland Clinic
Treatments:
Thiamine